TS-134, CSF
Showing 1 - 25 of 2,279
Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML) Trial run by the NHLBI
Completed
- Myelodysplastic Syndrome (MDS)
- +2 more
- WT1:126-134
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 15, 2021
Relapsing Multiple Sclerosis, Clinically Isolated Syndrome Trial in San Francisco (Ocrelizumab)
Recruiting
- Relapsing Multiple Sclerosis
- Clinically Isolated Syndrome
-
San Francisco, CaliforniaUniversity of California San Francisco
Apr 28, 2022
Fertility Attitudes of Adolescents and Young Turner Syndrome and
Recruiting
- Fertility Perservation
- Fertility
-
Bethesda, MarylandNational Institute of Child Health and Human Development (NICHD)
Feb 2, 2023
Multiple Sclerosis, Transcranial Direct Current Stimulation Trial in Istanbul (Transcutaneous Spinal Direct Current Stimulation)
Recruiting
- Multiple Sclerosis
- Transcranial Direct Current Stimulation
- Transcutaneous Spinal Direct Current Stimulation
-
Istanbul, Kadıköy, TurkeyCadde Tıp Merkezi
Oct 31, 2023
Observational Pilot Study With TachoSil as a Ventricular Sealant
Completed
- Intraventricular Neoplasm
-
Badalona, Barcelona, SpainHospital Universitari Germans Trias i Pujol
Feb 3, 2023
Healthy Male Subjects Trial in Tokyo ([14C] TS-142)
Completed
- Healthy Male Subjects
- [14C] TS-142
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
Neuropathic Pain Trial in Saint Louis (Ondansetron 8mg with Saline & Tariquidar, Ondansetron 16mg with Saline & Tariquidar)
Terminated
- Neuropathic Pain
- Ondansetron 8mg with Saline & Tariquidar
- Ondansetron 16mg with Saline & Tariquidar
-
Saint Louis, MissouriWashington University in St. Louis
Mar 28, 2022
Biliary Tract Cancer Trial in Kaohsiung, Taichung (D07001-softgel capsules + Xeloda (or TS-1), mFOLFOX)
Recruiting
- Biliary Tract Cancer
- D07001-softgel capsules + Xeloda (or TS-1)
- mFOLFOX
-
Kaohsiung, Taiwan
- +4 more
Dec 22, 2022
Healthy Volunteers Trial in Glendale (TS-134, Placebo)
Completed
- Healthy Volunteers
- TS-134
- Placebo
-
Glendale, CaliforniaPAREXEL - Early Phase Clinical Unit-Los Angeles
Nov 14, 2018
Post-Intubation Tracheal Stenosis and Covid-19
Recruiting
- Tracheal Stenosis
- +3 more
- tracheal stenosis follow-up file
-
Çankaya, Ankara, TurkeyAnkara City Hospital
Jan 11, 2023
based Approaches for Improving Diagnosis of Childhood
Recruiting
- Tuberculous Meningitis
-
Cape Town, Western Cape, South AfricaStellenbosch University Immunology Research Group
May 16, 2022
Multiple Sclerosis Trial in Saint Louis (SOMAscan)
Recruiting
- Multiple Sclerosis
- SOMAscan
-
Saint Louis, MissouriWashington University in St Louis
Apr 25, 2022
Patients With Mild or Moderate Hepatic Impairment Trial in Tokyo (TS-142 5 mg)
Recruiting
- Patients With Mild or Moderate Hepatic Impairment
- TS-142 5 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Dec 27, 2022
Effect of Food Trial in Tokyo (TS-142 10 mg)
Not yet recruiting
- Effect of Food
- TS-142 10 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Jan 22, 2023
Hyperphosphatemia Patients on Hemodialysis Trial in Tokyo (TS-172 10mg bid, TS-172 30mg bid, TS-172 60mg bid)
Not yet recruiting
- Hyperphosphatemia Patients on Hemodialysis
- TS-172 10mg bid
- +4 more
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Jan 23, 2023
Dental Implant, Dental Implant-Abutment Design Trial in Sassari (Implant placement)
Not yet recruiting
- Dental Implant
- Dental Implant-Abutment Design
- Implant placement
-
Sassari, ItalyMarco Tallarico
Apr 24, 2023
Healthy Volunteer, MDD, Depression Trial run by the NIMH (drug, other, device)
Recruiting
- Healthy Volunteer
- +2 more
- Ketamine
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 12, 2023
Tetraplegia/Tetraparesis Trial in Richmond (BES + TS, Experimental: BES+sham TS)
Recruiting
- Tetraplegia/Tetraparesis
- BES + TS
- Experimental: BES+sham TS
-
Richmond, Virginia
- +2 more
Jun 24, 2022
The Next-day Residual Effects Trial in Tokyo (TS-142, Zopiclone, Placebo)
Not yet recruiting
- The Next-day Residual Effects
- TS-142
- +2 more
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Apr 6, 2023
Healthy Subjects Trial in Toshima-ku (TS-142, Moxifloxacin, Placebo)
Completed
- Healthy Subjects
- TS-142
- +2 more
-
Toshima-ku, JapanTaisho Pharmaceutical Co., Ltd selected site
Oct 5, 2022
Anatomical and Perioperative Predisposing Factor for Limb
Completed
- Aneurysm Abdominal
-
Milan, ItalyIRCCS Ospedale San Raffaele
Nov 10, 2022
Refractix DSP and TS Meter-DSP Measurement Comparison
Not yet recruiting
- Healthy
- Serum Total Protein Measurement with TS Meter-DSP and Refractix DSP
-
Lauderhill, FloridaHemarus Plasma
Jan 30, 2023
Turner Syndrome, Short Stature Trial in Washington (Vosoritide)
Not yet recruiting
- Turner Syndrome
- Short Stature
-
Washington, District of ColumbiaChildren's National Hospital
Apr 28, 2023
Post-cesarean Pain Trial in Columbus (TrueRelief device, Sham TrueRelief device)
Recruiting
- Post-cesarean Pain
- TrueRelief device
- Sham TrueRelief device
-
Columbus, OhioThe Ohio State University Wexner Medical Center OB/GYN Maternal
May 31, 2022